Healthcare -
Biotechnology - NASDAQ - US
$ 54.8
-1.03 %
$ 6.97 B
Market Cap
18.15
P/E
HALO - CAPITAL EXPENDITURES
Capital Expenditures HALO - Halozyme Therapeutics, Inc.
-15.3 M
LAST VALUE
-223.99%
2 YEAR CAGR
-26.82%
5 YEAR CAGR
-20.87%
10 YEAR CAGR